Barchart.com
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Iqvia Holdings Inc (IQV)

Iqvia Holdings Inc (IQV)
177.18 x 100 181.88 x 100
Post-market by (Cboe BZX)
179.36 -0.66 (-0.37%) 03/27/25 [NYSE]
177.18 x 100 181.88 x 100
Post-market 179.36 unch (unch) 16:36 ET
News & Headlines for Thu, Mar 27th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Paychex Q3 Earnings & Revenues Surpass Estimates, Increase Y/Y
Paychex Q3 Earnings & Revenues Surpass Estimates, Increase Y/Y Zacks Investment Research - Wed Mar 26, 11:02AM CDT

Paychex, Inc. PAYX has reported impressive third-quarter fiscal 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.See Zacks Earnings Calendar to stay ahead of market-making...

PAYX : 151.83 (+1.09%)
IT : 424.89 (-0.44%)
IQV : 179.36 (-0.37%)
IQV
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks StockStory - Wed Mar 26, 4:03AM CDT

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

FTRE : 8.36 (-1.07%)
UFPT : 203.23 (-0.15%)
AZTA : 35.52 (-2.44%)
RGEN : 137.12 (-1.66%)
IQV : 179.36 (-0.37%)
WST
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks StockStory - Tue Mar 25, 4:07AM CDT

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 8.36 (-1.07%)
UFPT : 203.23 (-0.15%)
AZTA : 35.52 (-2.44%)
WST : 226.06 (+0.51%)
IQV : 179.36 (-0.37%)
IQV
3 Reasons IQV is Risky and 1 Stock to Buy Instead StockStory - Wed Mar 19, 4:09AM CDT

3 Reasons IQV is Risky and 1 Stock to Buy Instead

CRWD : 366.56 (-1.31%)
IQV : 179.36 (-0.37%)
FTRE
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE) StockStory - Tue Mar 18, 4:04AM CDT

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 8.36 (-1.07%)
MEDP : 316.61 (-0.33%)
AZTA : 35.52 (-2.44%)
WST : 226.06 (+0.51%)
IQV : 179.36 (-0.37%)
IQVIA Holdings Inc logo and chart-by IgorGolovniov via Shutterstock
Is IQVIA Holdings Stock Underperforming the Dow? Barchart - Thu Mar 13, 2:25AM CDT

IQVIA Holdings has significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s prospects.

A : 118.97 (-0.78%)
$DOWI : 42,299.70 (-0.37%)
IQV : 179.36 (-0.37%)
IQV : 179.36 (-0.37%)
RGEN
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack StockStory - Tue Mar 11, 4:01AM CDT

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

FTRE : 8.36 (-1.07%)
MEDP : 316.61 (-0.33%)
RGEN : 137.12 (-1.66%)
AZTA : 35.52 (-2.44%)
IQV : 179.36 (-0.37%)
CRL
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4 StockStory - Wed Mar 5, 3:01AM CST

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 8.36 (-1.07%)
MEDP : 316.61 (-0.33%)
AZTA : 35.52 (-2.44%)
CRL : 158.06 (-0.12%)
IQV : 179.36 (-0.37%)
Nvidia logo and sign on headquarters by Michael Vi via Shutterstock
Rep. Marjorie Taylor Greene Is Betting Big on Nvidia Stock. Should You? Barchart - Thu Feb 20, 9:36AM CST

The politician last disclosed a purchase worth up to $15,000 in NVDA in January.

NVDA : 111.43 (-2.05%)
GOOGL : 162.24 (-1.71%)
AAPL : 223.85 (+1.05%)
TSLA : 273.13 (+0.39%)
ILMN : 82.28 (-0.66%)
MET : 83.05 (-1.05%)
AMZN : 201.36 (+0.11%)
IQV : 179.36 (-0.37%)

Barchart Exclusives

Marjorie Taylor Greene Loves This High-Yield Dividend Stock. Should You Buy It Too? Barchart - Thu Mar 27, 6:30PM CDT
Congresswoman Marjorie Taylor Greene’s recent investment in Devon Energy has brought attention to the stock, which boasts a strong financial performance, attractive valuation, and growing dividend. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies
Wed, Apr 02, 2025 5:00 PM UTC
Reserve Your Spot